These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 728122)

  • 1. Purification of a lymphokine: osteoclast activating factor from human tonsil lymphocytes.
    Luben RA
    Biochem Biophys Res Commun; 1978 Sep; 84(1):15-22. PubMed ID: 728122
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effects of osteoclast-activating factor (OAF) on the absorption of alveolar bone. 1. Production and purification of OAF (author's transl)].
    Marumoto Y; Kusunoki K; Fijihashi H; Osaka H; Nakamura Y; Ikeda K
    Nihon Shishubyo Gakkai Kaishi; 1982 Mar; 24(1):121-7. PubMed ID: 6980245
    [No Abstract]   [Full Text] [Related]  

  • 3. Purification and partial sequence of human osteoclast-activating factor: identity with interleukin 1 beta.
    Dewhirst FE; Stashenko PP; Mole JE; Tsurumachi T
    J Immunol; 1985 Oct; 135(4):2562-8. PubMed ID: 3875658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine A inhibits calcemic hormone-induced bone resorption in vitro.
    Stewart PJ; Green OC; Stern PH
    J Bone Miner Res; 1986 Jun; 1(3):285-91. PubMed ID: 3503544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for the production and quantitative assay of human lymphokine preparations.
    Warren HS; Pembrey RG
    J Immunol Methods; 1981; 41(1):9-21. PubMed ID: 7264312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Observations on the mechanism of bone resorption induced by multiple myeloma marrow culture fluids and partially purified osteoclast-activating factor.
    Josse RG; Murray TM; Mundy GR; Jez D; Heersche JN
    J Clin Invest; 1981 May; 67(5):1472-81. PubMed ID: 6262378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lymphokine-like factor isolated by deoxycholate from the membrane of human lymphocytes.
    Hrabák A; Antoni F; Szabó MT
    Biochim Biophys Acta; 1980 Oct; 602(1):87-96. PubMed ID: 7417452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of new osteoclast formation by a bone cell-derived macromolecular factor.
    Dickson IR; Scheven BA
    Biochem Biophys Res Commun; 1989 Mar; 159(3):1383-90. PubMed ID: 2930568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human T-cell growth factor: purification biochemical characterization, and interaction with a cellular receptor.
    Robb RJ
    Immunobiology; 1982 Mar; 161(1-2):21-50. PubMed ID: 7047366
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of glucocorticoids on osteoclast-activating factor.
    Strumpf M; Kowalski MA; Mundy GR
    J Lab Clin Med; 1978 Nov; 92(5):772-8. PubMed ID: 712208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A study of the mechanism of lymphokine production and release.
    Korcáková L; Smetana K; Svobodová J
    Folia Biol (Praha); 1980; 26(2):140-4. PubMed ID: 6155295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current aspects of tonsillar morphology and physiopathology].
    Obreja S; Fotescu L
    Rev Chir Oncol Radiol O R L Oftalmol Stomatol Otorinolaringol; 1981; 26(4):241-55. PubMed ID: 6211723
    [No Abstract]   [Full Text] [Related]  

  • 13. A "cytotoxic" factor released from unactivated human lymphocytes.
    Szabó MT; Antoni F
    Acta Biochim Biophys Acad Sci Hung; 1975; 10(1-2):31-6. PubMed ID: 1146491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preliminary characterization of human T cell suppressor factor (HTsF) isolated from tonsil cells by monoclonal antibody immunoadsorbence.
    Steele JK; Stammers AT; Levy JG
    J Immunol; 1985 Aug; 135(2):1201-6. PubMed ID: 3159788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Osteoclast activating factor - a new humoral agent influencing pathological bone resorption].
    Zák J; Pacovský V
    Cas Lek Cesk; 1982 Aug; 121(32):993-5. PubMed ID: 6751542
    [No Abstract]   [Full Text] [Related]  

  • 16. Apoptosis of germinal centers in postnatal development of rabbit tonsil.
    Kawabata I; Homma T; Tabe H; Koba R
    Acta Otolaryngol Suppl; 1996; 523():60-3. PubMed ID: 9082811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abstracts from Fourth International Lymphokine Workshop. Molecular and cellular biology of lymphokines. October l7-21, 1984.
    Lymphokine Res; 1984; 3(4):229-85. PubMed ID: 6436585
    [No Abstract]   [Full Text] [Related]  

  • 18. Biochemical and biological characterization of lymphocyte regulatory molecules. I. Purification of a class of murine lymphokines.
    Watson J; Gillis S; Marbrook J; Mochizuki D; Smith KA
    J Exp Med; 1979 Oct; 150(4):849-61. PubMed ID: 315987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukemia inhibitory factor: a novel bone-active cytokine.
    Reid LR; Lowe C; Cornish J; Skinner SJ; Hilton DJ; Willson TA; Gearing DP; Martin TJ
    Endocrinology; 1990 Mar; 126(3):1416-20. PubMed ID: 2106430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative evaluation of the functional properties of the tonsillar lymphocytes in tonsillogenic lesions of the heart].
    Isaakian SA; Melikian NG; Minasarian IT; Aladzhian SP
    Zh Eksp Klin Med; 1979; 19(5):97-100. PubMed ID: 525111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.